Locations:
SearchReducing this critical interval is complex, but patients benefit
Image content: This image is available to view online.
View image online (https://assets.clevelandclinic.org/transform/3080f725-f3ed-4a57-b22c-5d92f9a62c6b/conversation_650x450_jpg)
conversation_650x450
The time between a cancer diagnosis and the initiation of treatment can be lonely and anxious for patients. Shortening this critical interval is a complicated logistical problem, but benefits patients medically and psychologically, thereby improving outcomes and adding value.
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
In this video — part of a series on value-based cancer care — Taussig Cancer Institute Chairman Brian J. Bolwell, MD, FACP, discusses Cleveland Clinic Cancer Center’s commitment to reducing time to treatment.
Video content: This video is available to watch online.
View video online (https://www.youtube.com/embed/Zbyichdmx0o?feature=oembed)
Click here to view more cancer related videos.
Photo Credit ©Russell Lee
Advertisement
Advertisement
First-of-its-kind research investigates the viability of standard screening to reduce the burden of late-stage cancer diagnoses
Global R&D efforts expanding first-line and relapse therapy options for patients
Study demonstrates ability to reduce patients’ reliance on phlebotomies to stabilize hematocrit levels
A case study on the value of access to novel therapies through clinical trials
Findings highlight an association between obesity and an increased incidence of moderate-severe disease
Cleveland Clinic Cancer Institute takes multi-faceted approach to increasing clinical trial access 23456
Key learnings from DESTINY trials
Overall survival in patients treated since 2008 is nearly 20% higher than in earlier patients